Cyclic Nigerosyl-Nigerose as Oxygen Nanocarrier to Protect Cellular Models from Hypoxia/Reoxygenation Injury: Implications from an In Vitro Model
, Fabrizio Caldera 3, Alberto Rubin Pedrazzo 3, Claudio Cecone 3, Edoardo Alfì 1, Stefano Comità 1, Takanobu Higashiyama 4, Francesco Trotta 3,*, Pasquale Pagliaro 1,* and Roberta Cavalli 5,*
Round 1
Reviewer 1 Report
Penna et al., have addressed the concerns highlighted in their previous version of the manuscript.
Major concern:
Figure 8: The information presented in the Western blots are difficult to interpret. Please add a densitometric analysis alongside.
Minor concerns:
Methods. Section 4.8. Western blot analysis
i) Line 348: Figure 9, in place of 99.
ii) Please mention the sources of the antibodies individually, including their dilution; the relevant secondary antibodies, and their source(s) as well.
Author Response
We thanks the referee for the vakuable suggestions. We have modified as requested the Western Blot and corrected the minor concerns.
Reviewer 2 Report
Thanks for addressing all the comments
Author Response
The authors thank the referee for well considering the revision.
Reviewer 3 Report
All mistakes were corrected by authors
Author Response
The authors thank the reviewer for the positive response.
